CDNA CAREDX INC
2026Q1 · CUSIP 14167L103 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
189
Δ holders QoQ
-12
Breadth percentile
Top 88%
Whale holders
108
Δ whales
+6
Inst. holding value
$907M
New positions
25
Closed positions
37
Price momentum (1Q)
+5.9%
Put / Call
0/1
Breadth history (34 quarters)
Past Lit Events & Aftermath 7 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q3 | Top 3% | +3.4% | -20.6% |
| 2020Q4 | Top 17% | -22.8% | -19.1% |
| 2020Q2 | Top 6% | +59.0% | +148.7% |
| 2019Q1 | Top 6% | -27.8% | -41.2% |
| 2018Q3 | Top 3% | -6.4% | +10.9% |
| 2018Q2 | Top 6% | +54.7% | +54.1% |
| 2018Q1 | Top 17% | +55.2% | +140.1% |
Options Sentiment
Put holders
0
QoQ: 0
Call holders
1
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.16
EPS YoY
-114.3%
Revenue (TTM)
$0.4B
Revenue YoY
+19.2%
Net margin
-2.0%
ROE
-2.6%
Debt ratio
23.7%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.